HPV vaccination and cervical cancer screening

Affiliations

¹ Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan; Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Electronic address: sae.joy1056210@gmail.com.
² Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan; Tohoku University School of Medicine, Sendai, Miyagi, Japan.
³ Department of Internal Medicine, Navitas Clinic Shinjuku, Shinjuku, Tokyo, Japan.
⁴ Department of Internal Medicine, Navitas Clinic Tachikawa, Tachikawa, Tokyo, Japan.
⁵ Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan.

Comment

Sae Kamamoto et al. Lancet. 2022.

. 2022 May 21;399(10339):1939-1940.

doi: 10.1016/S0140-6736(22)00106-4.

¹ Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan; Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. Electronic address: sae.joy1056210@gmail.com.
² Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan; Tohoku University School of Medicine, Sendai, Miyagi, Japan.
³ Department of Internal Medicine, Navitas Clinic Shinjuku, Shinjuku, Tokyo, Japan.
⁴ Department of Internal Medicine, Navitas Clinic Tachikawa, Tachikawa, Tokyo, Japan.
⁵ Medical Governance Research Institute, Minato-ku, Tokyo 1087505, Japan.

No abstract available

Comment in

HPV vaccination and cervical cancer screening - Authors' reply.
Sasieni P, Castanon A. Sasieni P, et al. Lancet. 2022 May 21;399(10339):1940. doi: 10.1016/S0140-6736(22)00240-9. Lancet. 2022. PMID: 35598622 No abstract available.

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. Falcaro M, et al. Lancet. 2021 Dec 4;398(10316):2084-2092. doi: 10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3. Lancet. 2021. PMID: 34741816